Yoshinori Imamura

Has grant

Assistant Professor

Kobe University Hospital

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Yoshinori Imamura is an Assistant Professor at Kobe University Hospital in Japan. His research areas focus on the impact of immunotherapy and targeted therapies in the treatment of head and neck cancer, as well as the management of acute kidney injury in patients undergoing chemoradiotherapy. He has contributed to multiple studies addressing the clinical outcomes of EGFR-mutated non-small cell lung cancer and the efficacy of HPV-related oropharyngeal carcinoma treatments. His recent publications reflect his dedication to improving patient care and understanding the complexities of cancer treatments.

Recent Grants

Grant: Close

Predicting of venous thromboembolism in Japanese cancer patients

Open Date: 2018-04-01

Close Date: 2019-03-01

Grant: Close

The utility of 3D-culture models in testing the activity of chemotherapeutic drugs

Open Date: 2014-04-01

Close Date: 2015-03-01

Articles (16)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (10)

Hironobu Minami

JAPAN

View details

Yasuyuki Saito

Associate Professor

Kobe University Graduate School of Medicine

JAPAN

View details

Naomi Kiyota

Associate Professor

Kobe University Hospital

JAPAN

View details

Mitsuhiro Ito

Professor

Kobe University Graduate School of Medicine

JAPAN

View details

Yohei Funakoshi

Kobe University Hospital

JAPAN

View details

Goh Ohji

Associate professor

Kobe University

JAPAN

View details

Kouichi Ohe

Kyoto University

JAPAN

View details

YOSHIAKI NAGATANI

Kobe University Hospital

JAPAN

View details

Ichiro Ota

Associate Professor

Kindai University

JAPAN

View details

Masato Nagaoka

asistant professor

Jikei University School of Medicine

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Yoshinori Imamura

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (16)

Comparative review of KEYNOTE-689 and NIVOPOSTOP trials and their impact on perioperative immunotherapy in locally advanced head and neck cancer

Risk prediction model for cisplatin-induced acute kidney injury in patients with head and neck cancer receiving chemoradiotherapy: A re-analysis of a phase II/III JCOG1008 trial

Effect of acute kidney injury and overall survival in patients with postoperative head and neck cancer who received chemoradiotherapy with cisplatin: A supplementary analysis of the phase II/III trial of JCOG1008

Impact of First-Line Osimertinib and Other EGFR-Tyrosine Kinase Inhibitors on Overall Survival in Untreated Advanced EGFR-Mutated Non-small Cell Lung Cancer in Japan: Updated Data from TREAD Project 01

Prognostic impact of concomitant pH-regulating drugs in patients with non-small cell lung cancer receiving epidermal growth factor receptor tyrosine kinase inhibitors: the Tokushukai REAl-world Data project 01-S1

Stepwise prolongation of overall survival from first to third generation EGFR-TKIs for EGFR mutation-positive non-small-cell lung cancer: the Tokushukai REAl-world Data project (TREAD 01)

Promising Efficacy of a Third Dose of mRNA SARS-CoV-2 Vaccination in Patients Treated with Anti-CD20 Antibody Who Failed 2-Dose Vaccination

Transition of the PD‑1 occupancy of nivolumab on T cells after discontinuation and response of nivolumab re‑challenge

Safety and immunogenicity of the COVID-19 vaccine BNT162b2 in patients undergoing chemotherapy for solid cancer

Identification of Breast Cancer Stem Cells Using a Newly Developed Long-acting Fluorescence Probe, C5S-A, Targeting ALDH1A1

Human papillomavirus-related oropharyngeal carcinoma

Limited increase in antibody titers following mRNA SARS-CoV-2 vaccination for more than 3 years after final dose of anti-CD20 antibody.

Real-World Outcomes of Systemic Therapy in Japanese Patients with Cancer (Tokushukai REAl-World Data Project: TREAD): Study Protocol for a Nationwide Cohort Study

Management of elderly patients with head and neck cancer

Systemic therapy for salivary gland malignancy: current status and future perspectives

Apixaban in Japanese patients with cancer-associated venous thromboembolism: a multi-center phase II trial

Collaborators (10)

Hironobu Minami

Yasuyuki Saito

Naomi Kiyota

Mitsuhiro Ito

Yohei Funakoshi

Goh Ohji

Kouichi Ohe

YOSHIAKI NAGATANI

Ichiro Ota

Masato Nagaoka

Make your next move.